ArticleTranslational oncology2021

Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis.

Yanmei Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.